FDMT   $8.58  0.59% Market Closed After Close 8.5 -0.93%

4D Molecular Therapeutics Inc
Total Cash 541.95M
totalCashPerShare 10.428
EBITDA -126.75M
Total Debt 13.66M
quickRatio 27.931
currentRatio 28.482
Total Revenue 20.22M
debtToEquity 2.321
Revenue/Share 0.426
ROA -0.16864
ROE -0.24059999
grossProfits
freeCashflow -52.98M
operatingCashflow -85.15M
earningsGrowth
revenueGrowth -0.979
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -8491.2
profitMargins 0.0
enterpriseValue -84.99M
forwardPE -2.6079028
floatShares 26.40M
sharesOutstanding 51.97M
sharesShort 10.93M
sharesShortPriorMonth 9.87M
dateShortInterest
sharesPercentSharesOut 0.21%
heldPercentInsiders 0.03%
heldPercentInstitutions 1.13%
Short Ratio help_outline 11.42%
shortPercentOfFloat 0.22%
impliedSharesOutstanding
bookValue 11.333
Price To Book help_outline 0.76
earningsQuarterlyGrowth
netIncomeToCommon -109.89M
trailingEps -2.24%
forwardEps -3.29%
enterpriseToEbitda 0.67
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.7 3Q 2024
institutionsCount 221
lastUpdated Oct. 22, 2024, 12:26 a.m.